19736 Federal Register / Vol. 63, No. 76 /Tuesday, April 21, 1998 / Notices

Notice of this meeting is given under

the Federal Advisory Committee Act (5

U.S.C. app. 2).

Dated: April 14, 1998.

Michael A. Friedman,

Deputy Commissioner for Operations.

[FR Doc. 98–10406 Filed 4–20–98; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Resources and Services

Administration

Council on Graduate Medical

Education Meeting

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), announcement is

made of the following National

Advisory body scheduled to meet

during the month of May 1998:

Name: Council on Graduate Medical

Education.

Date and Time: May 6, 1998, 1:00 p.m.–

5:00 p.m.; May 7, 1998, 8:30 a.m.–12:00 p.m.

Place: Bethesda Ramada, 8400 Wisconsin

Avenue, Bethesda, MD.

This meeting is open to the Public.

Agenda: The agenda will include: opening

comments, welcome, and presentations from

the Acting Administrator, Health Resources

and Services Administration, the Acting

Associate Administrator for Health

Professions and the Acting Executive

Secretary of COGME; a panel on financing

graduate medical education to include cost,

financing and related issues in GME;

Medicare proposed rules on GME payment to

non-hospital providers; and GME

restructuring at the Department of Veterans

Affairs. In addition, there will be a

presentation on family physician supply

projections for rural areas; action on a draft

report on Physician Competencies; a

discussion of work group activities and

papers; and a discussion of Council work and

direction.

Anyone requiring information regarding

the subject should contact F. Lawrence Clare,

M.D., M.P.H., Deputy Executive Secretary,

telephone (301) 443–6326, Council on

Graduate Medical Education, Division of

Medicine, Bureau of Health Professions,

Room 9A–27, Parklawn Building, 5600

Fishers Lane, Rockville, Maryland 20857.

Agenda items are subject to change as

priorities dictate.

Dated: April 15, 1998.

Jane Harrison,

Director, Office of Policy and Information

Coordination.

[FR Doc. 98–10469 Filed 4–20–98; 8:45 am]

BILLING CODE 4160–15–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood

Institute; Notice of Meeting of the

Sickle Cell Disease Advisory

Committee

Pursuant to Public Law 92–463,

notice is hereby given of the meeting of

the Sickle Cell Disease Advisory

Committee, National Heart, Lung, and

Blood Institute, June 8, 1998. The

meeting will be held at the National

Institutes of Health, Rockledge II,

Conference Room 9104, 6701 Rockledge

Drive, Bethesda, Maryland 20892.

The entire meeting will be open to the

public from 9:00 a.m. to adjournment, to

discuss recommendations on the

implementation and evaluation of the

Sickle Cell Disease Program. Attendance

by the public will be limited to space

available.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations should

contact the Executive Secretary in

advance of the meeting.

Dr. Clarice D. Reid, Executive

Secretary, Sickle Cell Disease Advisory

Committee, Division of Blood Diseases

and Resources NHLBI, Two Rockledge

Center, Suite 10160, 6701 Rockledge

Drive, Bethesda, Maryland 20892 (301)

435–0080, will furnish substantive

program information, a summary of the

meeting, and a roster of the committee

members.

(Catalog of Federal Domestic Assistance

Program No. 93.839, Blood Diseases and

Resources Research, National Institutes of

Health)

Dated: April 14, 1998.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 98–10439 Filed 4–20–98; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood

Institute; Notice of Meeting of Board of

Scientific Counselors

Pursuant to Public Law 92–463,

notice is hereby given of the meeting of

the Board of Scientific Counselors,

National Heart, Lung, and Blood

Institute at 8:00 a.m. on June 4–5, 1998,

National Institutes of Health, 9000

Rockville Pike, Building 10, Room

7S235, Bethesda, Maryland 20892.

In accordance with the provisions set

forth in section 552b(c)(6), Title 5,

U.S.C. and section 10(d) of Public Law

92–463, the entire meeting will be

closed to the public for the review,

discussion, and evaluation of individual

programs and projects conducted by the

National Institutes of Health, including

consideration of personnel

qualifications and performance, the

competence of individual investigators,

and similar items, the disclosure of

which would constitute a clearly

unwarranted invasion of personal

privacy.

Dr. Edward D. Korn, Executive

Secretary and Director, Division of

Intramural Research, NHLBI, NIH,

Building 10, Room 7N214, (301) 496–

2116, will furnish substantive program

information.

Dated: April 14, 1998.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 98–10440 Filed 4–20–98; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood

Institute; Notice of Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Heart, Lung, and Blood

Institute Special Emphasis Panel (SEP)

meeting:

Name of SEP: New Approaches to Improve

the Viability and Function of Transfused

Platelets.

Date: May 5, 1998.

Time: 8:00 a.m.

Place: Holiday Inn Bethesda, 8120

Wisconsin Avenue, Bethesda, Maryland

20814.

Contact Person: Jon M. Ranhand, Ph.D.,

Two Rockledge Center, Room 7188, 6701

Rockledge Drive, Bethesda, MD 20892–7924,

(301) 435–0280.

Purpose/Agenda: To review and evaluate

grant applications.

This meeting will be closed in accordance

with the provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Programs Nos. 93.837, Heart and Vascular

Diseases Research; 93.838, Lung Diseases